Save
SARM1 deletion protects axons in a model of inflammatory demyelination
ECTRIMS Online Library, Raul Krauss, 278690
k free light chains for multiple sclerosis diagnosis
ECTRIMS Online Library, Luisa Agnello, 278706
Closing
ECTRIMS Online Library, Jan Hillert, 281890
The German experience
ECTRIMS Online Library, Heinz Wiendl, 281889
Learnings from MSBase
ECTRIMS Online Library, Sue Hodgkinson, 281888
Bridging the MS practice gap with innovative registry studies
ECTRIMS Online Library, Jan Hillert, 281887
Welcome and objectives
ECTRIMS Online Library, Mitzi Williams, 281886
Oxcarbazepine as a neuroprotective agent in MS: a phase IIa trial (PROXIMUS)
ECTRIMS Online Library, Monica Marta, 279519
A study of MRI cortical lesions in myelin oligodendrocyte glycoprotein antibody associated disease
ECTRIMS Online Library, Rosa Cortese, 279524
School performance and psychiatric morbidity 6 years after paediatric acute disseminated encephalomyelitis: a nationwide population-based cohort study
ECTRIMS Online Library, Magnus Spangsberg Boesen, 279528
Environmental enrichment induces microglia polarization and neurotrophin production in a focal chronic cortical model of multiple sclerosis
ECTRIMS Online Library, Berenice Anabel Silva, 279518
Peripheral nervous system involvement in MOG antibody-associated demyelination
ECTRIMS Online Library, Sudarshini Ramanathan, 279523
Cognitive processing speed in pediatric-onset MS: baseline characteristics of impairment and predictors of decline
ECTRIMS Online Library, Lauren Krupp, 279527
Non-invasive blood epigenetic biomarkers of CNS cell loss
ECTRIMS Online Library, Eitan Akirav, 279530
A large international aquaporin-4 antibody data set: combines individual factors to predict prognosis, identifies the risk of post-onset attack disability and calculates the power for future clinical trials
ECTRIMS Online Library, Ichiro Nakashima, 279517
Perivenous inflammatory demyelination with MOG-dominant myelin loss is a characteristic feature of MOG antibody-associated disease
ECTRIMS Online Library, Yoshiki Takai, 279522
Real-world effectiveness of initial treatment with newer versus injectable disease-modifying therapies in pediatric multiple sclerosis in the US
ECTRIMS Online Library, Kristen M Krysko, 279526
Ensuring an effective training to deal with mobility loss
ECTRIMS Online Library, Anders Guldhammer Skjerbæk, 279532
Epigenetics as a therapeutic/environmental mediator in MS
ECTRIMS Online Library, Achilles Ntranos, 279529
Population-based head-to-head comparative studies of the epidemiology of neuromyelitis optica spectrum disorder (NMOSD) in Europe
ECTRIMS Online Library, Viktoria Papp, 279516
Anti-AQP4 antibodies positive neuromyelitis optica syndrome in children : an European-Brazilian collaborative study
ECTRIMS Online Library, Kumaran Deiva, 279525
Higher efficacy therapies appear to have a disproportionately larger effect in younger patients
ECTRIMS Online Library, Brandi Vollmer, 279515
MOG-antibodies and multiple sclerosis in adults: a large multicentre cross-sectional study
ECTRIMS Online Library, Alvaro Cobo- Calvo, 279520
Diagnosing and treating gait problems using gait analysis
ECTRIMS Online Library, Vincent de Groot, 279531
Everything is possible: a memorial honoring a pioneer in pediatric multiple sclerosis
ECTRIMS Online Library, Brenda Banwell, 281875
Can we learn about MS brain from epigenetic changes?
ECTRIMS Online Library, Maja Jagodic, 281876
High levels of perivascular inflammation and active white matter lesions at time of death are associated with rapidly progressive multiple sclerosis
ECTRIMS Online Library, Damiano Marastoni, 279493
A multiple sclerosis disease progression measure based on rate of cumulative disability
ECTRIMS Online Library, Ryan Ramanujam, 279499
A large case-control study on vaccination as risk factor of multiple sclerosis
ECTRIMS Online Library, Christiane Gasperi, 279504
A novel home-based digital treatment to improve processing speed in people with multiple sclerosis: a pilot study
ECTRIMS Online Library, Riley Bove, 279510
Molecular signatures of different lesions types in the white matter of SPMS
ECTRIMS Online Library, Maria Louise Elkjaer, 279492
Remotely monitored ambulatory activity correlates with MS disability not only for ambulation but also for MRI atrophy metrics, cognition and quality of life: baseline analysis from the SPI2 clinical trial of MD1003 in progressive MS
ECTRIMS Online Library, Valerie Block, 279498
The iMSMS: a multi-city, household controlled, gut microbiome study in multiple sclerosis
ECTRIMS Online Library, Xiaoyuan Zhou, 279503
Study of mental rotation in a cohort of patients with relapsing remitting multiple sclerosis: case control study
ECTRIMS Online Library, Mariangela Fratino, 279509
Interpretation of analytical/deductive statistics
ECTRIMS Online Library, Florian Deisenhammer, 279514
Vaccines and DMTs
ECTRIMS Online Library, Sandra Vukusic, 281872
Inflammatory lesion activity in chronic progressive MS is related to the accumulation and infiltration of tissue resident memory T cells
ECTRIMS Online Library, Nina Louise Fransen, 279491
Advancing walking measurement in multiple sclerosis clinical trials: a new patient-reported outcome measure
ECTRIMS Online Library, Jeremy Hobart, 279497
Serological response against HHV-6A is associated with increased risk for multiple sclerosis
ECTRIMS Online Library, Anna Fogdell-Hahn, 279502
Cognitive rehabilitation in patients with advanced progressive multiple sclerosis: possible within limits?
ECTRIMS Online Library, Stefanos Enricos Prouskas, 279508
Long-term follow-up on clinical, radiographic and cognitive outcomes in pathologically confirmed CNS inflammatory demyelinating disease
ECTRIMS Online Library, Alicja Kalinowska-Lyszczarz, 279490
Multiple sclerosis performance test (MSPT): a demographically stratified normative database (N = 517) of healthy subjects ages 15-89 to aid clinical interpretation of MS patient neuroperformance
ECTRIMS Online Library, Megan Sokolowski, 279496
MS risk loci are underrepresented in EBV induced DNA hypomethylation
ECTRIMS Online Library, Lawrence Ong, 279501
Memory improvement after a cognitive rehabilitation program in multiple sclerosis
ECTRIMS Online Library, Helene Brissart, 279507
Vaccines and the risk of relapses
ECTRIMS Online Library, Jette Frederiksen, 279512
Data analyses, interpretation, misinterpretation, and biases
ECTRIMS Online Library, Maria Pia Sormani, 279513
Potential biological mechanisms behind MS progression
ECTRIMS Online Library, Jack Van Horssen, 279489
The role of EBV in MS immunology?
ECTRIMS Online Library, Christian Münz, 279500
Cognitive rehabilitation for attention and memory in multiple sclerosis: results of the CRAMMS trial
ECTRIMS Online Library, Roshan das Nair, 279506
Neuro-QoL in MS – tomorrow’s standard outcome?
ECTRIMS Online Library, Deborah Miller, 281869
Multiple sclerosis pathogenesis: what are the missing pieces?
ECTRIMS Online Library, Wolfgang Brück, 279488
Cognitive strategy training - a curse or blessing?
ECTRIMS Online Library, Päivi Hämäläinen, 279505
Cognitive assessment in MS – rationale and tools
ECTRIMS Online Library, Dawn Langdon, 281868
Vaccines and the risk of MS
ECTRIMS Online Library, Jorge Correale, 281871
How to assess and summarize study
ECTRIMS Online Library, Elena Hernández Martínez-Lapiscina, 281873
Preserving patient function
ECTRIMS Online Library, Robert Bermel, 281858
The changing treatment paradigm
ECTRIMS Online Library, Fredrik Piehl, 281857
Understanding MS disease progression
ECTRIMS Online Library, Jerry S. Wolinsky, 281856
Satellite Symposium 6: MS: time to shift our focus: Q&A and Close
ECTRIMS Online Library, Session Speakers, 281948
Satellite Symposium 7: Challenging our understanding of the MS spectrum: an expert panel discussion
ECTRIMS Online Library, Session Speakers, 281949
Satellite Symposium 6: MS: time to shift our focus: Welcome
ECTRIMS Online Library, Fredrik Piehl, 285138
Rituximab is not a reasonable alternative in MS treatment
ECTRIMS Online Library, Mitchell Wallin, 279477
Pathogenesis of human antibodies against MOG
ECTRIMS Online Library, Edgar Meinl, 279483
Case #2: When to stop in stop in secondary progressive multiple sclerosis (SPMS) patient
ECTRIMS Online Library, Gilles Edan, 279487
Symptomatic pharmacotherapy and patient education strategies in progressive MS – an inventory
ECTRIMS Online Library, Jaume Sastre-Garriga, 281851
PROMs in standardized MS care
ECTRIMS Online Library, Alessandra Solari, 281854
Neuromodulation: a potential approach to management of symptoms in MS
ECTRIMS Online Library, Letizia Leocani, 279479
The spectrum of demyelinating diseases in children
ECTRIMS Online Library, Brenda Banwell, 279482
PROMS: Supporting patient-centred care
ECTRIMS Online Library, Marcia Finlayson, 279485
Rituximab is a reasonable alternative in MS treatment
ECTRIMS Online Library, Fredrik Piehl, 281850
Main challenges in symptomatic MS treatment
ECTRIMS Online Library, Elisabeth Maillart, 279478
Rationale of B-cell therapy in MS
ECTRIMS Online Library, David Baker, 281849
New emerging treatments in NMOSD
ECTRIMS Online Library, Brian Weinshenker, 281852
20 years of MSIS-29 – importance of an MS specific QoL scale
ECTRIMS Online Library, Jeremy Hobart, 281853
Sustained reduction in confirmed disability progression in patients with primary progressive multiple sclerosis treated with ocrelizumab in the open-label extension period of the Phase III ORATORIO trial: 6.5-study year follow-up data
ECTRIMS Online Library, Jerry S. Wolinsky, 279457
Influence of ultraviolet radiation and diminished-function melanocortin 1 receptor variants on multiple sclerosis disease severity in two large multicenter cohort studies
ECTRIMS Online Library, Patrick Ostkamp, 279461
Introducing Machine Learning for full MS patient trajectories improves predictions for disability score progression
ECTRIMS Online Library, Liesbet Peeters, 279466
Detection of subtle gait disturbance and future fall risk in early multiple sclerosis
ECTRIMS Online Library, Rachel Brandstadter, 279471
Siponimod delays the time to wheelchair in patients with SPMS: results from the EXPAND study
ECTRIMS Online Library, Patrick Vermersch, 279456
Utilizing epigenetics to understand mechanisms underlying primary progressive multiple sclerosis
ECTRIMS Online Library, Majid Pahlevan Kakhki, 279460
The relationship of change in Neuro-QoL to change in neuroperformance tests and MRI
ECTRIMS Online Library, Marisa McGinley, 279465
Effects of PR-Fampridine on gait pattern and patient-reported outcomes: a cross-over, randomized, placebo-controlled trial
ECTRIMS Online Library, Maxime Valet, 279470
Evolution of biological agents: how established drugs can become less safe
ECTRIMS Online Library, David Hunt, 281846
Therapeutic complement inhibition in neuroinflammatory diseases
ECTRIMS Online Library, Renato Mantegazza, 281848
Indications of neuroprotective effects in progressive multiple sclerosis following autologous mesenchymal stem cells (MSC) transplantation: report of a randomised phase IIb double blind trial
ECTRIMS Online Library, Panayiota Petrou, 279455
RNA-sequencing of leukocortical lesions from multiple sclerosis patients reveals little overlap in gene expression between white and grey matter demyelination
ECTRIMS Online Library, Thecla Anne van Wageningen, 279459
The progressive multiple sclerosis score: a prognostic assistant tool in multiple sclerosis disease
ECTRIMS Online Library, Anna Isabella Pisani, 279464
Virtual reality(VR)-based cognitive rehabilitation: cognitive games are complementary to physical training for an optimum rehabilitation strategy in patients with Multiple Sclerosis (MS)
ECTRIMS Online Library, Maryam Sadeghi, 279469
Defining the risk factors for the conversion to secondary progressive multiple sclerosis: a retrospective cohort study of the Italian MS Register
ECTRIMS Online Library, Pietro Iaffaldano, 279454
Post-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms
ECTRIMS Online Library, Nina Louise Fransen, 279458
Functional and structural visual pathway assessment in CIS patients
ECTRIMS Online Library, Angela Vidal-Jordana, 279463
Multiple sessions of transcranial direct current stimulation (tDCS) combined with aerobic physical activity improves walking speed
ECTRIMS Online Library, Giuseppina Pilloni, 279468
Using registry data to investigate drug safety in MS
ECTRIMS Online Library, Melinda Magyari, 281845
Antibody-mediated pathogenesis in central and peripheral neuroinflammatory disorders
ECTRIMS Online Library, Jeffrey L. Bennett, 281847
How to design RCTs for SPMS
ECTRIMS Online Library, Jeremy Chataway, 279453
To design, implement and sustain big data collection in MS
ECTRIMS Online Library, Helmut Butzkueven, 279462
Coping strategies when living with MS progression
ECTRIMS Online Library, Lauren B Strober, 279467
HLA variation and MS
ECTRIMS Online Library, Lars Fugger, 281842
DMTs in progressive MS 2019 – what remains to be achieved
ECTRIMS Online Library, Xavier Montalban, 281840
In search of genetic regulation of progression and severity of MS
ECTRIMS Online Library, Ingrid Kockum, 281841

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.


Save Settings